Article Details
Retrieved on: 2024-02-01 16:58:49
Tags for this article:
Click the tags to see associated articles and topics
Summary
Biotechnology company Protagonist Therapeutics partners with Takeda Pharmaceutical to advance rusfertide, a treatment for polycythemia vera. Deal includes hefty payments, royalties, co-promotion options in the U.S., and reflects biotech collaboration within the pharmaceutical industry.
Article found on: www.biopharmadive.com
This article is found inside other Hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here